Avanos Medical, Inc. (NYSE:AVNS) Shares Sold by The Manufacturers Life Insurance Company

The Manufacturers Life Insurance Company lessened its holdings in shares of Avanos Medical, Inc. (NYSE:AVNS) by 4.2% during the fourth quarter, HoldingsChannel reports. The fund owned 22,031 shares of the company’s stock after selling 965 shares during the period. The Manufacturers Life Insurance Company’s holdings in Avanos Medical were worth $351,000 at the end of the most recent reporting period.

Several other large investors have also recently bought and sold shares of AVNS. Quantbot Technologies LP purchased a new position in Avanos Medical in the fourth quarter valued at about $64,000. Tower Research Capital LLC TRC increased its stake in Avanos Medical by 493.3% in the 4th quarter. Tower Research Capital LLC TRC now owns 8,075 shares of the company’s stock valued at $129,000 after purchasing an additional 6,714 shares in the last quarter. KLP Kapitalforvaltning AS acquired a new position in Avanos Medical during the fourth quarter worth $162,000. Mariner LLC boosted its position in Avanos Medical by 18.0% during the fourth quarter. Mariner LLC now owns 10,655 shares of the company’s stock worth $170,000 after purchasing an additional 1,625 shares in the last quarter. Finally, US Bancorp DE grew its holdings in Avanos Medical by 18.0% in the fourth quarter. US Bancorp DE now owns 14,093 shares of the company’s stock valued at $224,000 after purchasing an additional 2,147 shares during the last quarter. Hedge funds and other institutional investors own 95.17% of the company’s stock.

Insider Buying and Selling

In other Avanos Medical news, SVP Kerr Holbrook sold 7,000 shares of Avanos Medical stock in a transaction on Thursday, March 6th. The shares were sold at an average price of $15.25, for a total value of $106,750.00. Following the completion of the transaction, the senior vice president now owns 82,047 shares of the company’s stock, valued at $1,251,216.75. The trade was a 7.86% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is available through this link. 2.64% of the stock is currently owned by insiders.

Analyst Upgrades and Downgrades

Separately, StockNews.com upgraded shares of Avanos Medical from a “hold” rating to a “buy” rating in a research report on Wednesday, March 19th.

Avanos Medical Trading Up 2.9%

Shares of AVNS opened at $13.12 on Friday. The company has a market capitalization of $606.54 million, a PE ratio of 38.58 and a beta of 1.13. The stock has a fifty day moving average of $13.19 and a two-hundred day moving average of $15.72. Avanos Medical, Inc. has a fifty-two week low of $11.84 and a fifty-two week high of $25.36. The company has a debt-to-equity ratio of 0.12, a quick ratio of 1.46 and a current ratio of 2.22.

Avanos Medical (NYSE:AVNS) last posted its earnings results on Tuesday, May 6th. The company reported $0.26 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.19 by $0.07. Avanos Medical had a net margin of 2.30% and a return on equity of 4.70%. The firm had revenue of $167.50 million during the quarter, compared to the consensus estimate of $161.75 million. During the same quarter in the prior year, the company earned $0.22 EPS. The company’s revenue was up .8% on a year-over-year basis. As a group, analysts forecast that Avanos Medical, Inc. will post 1.32 EPS for the current year.

About Avanos Medical

Avanos Medical, Inc, a medical technology company, offers medical device solutions in North America, Europe, the Middle East, Africa, the Asia Pacific, and Latin America. It offers a portfolio of chronic care products that include digestive health products, such as Mic-Key enteral feeding tubes, Corpak patient feeding solutions, and NeoMed neonatal and pediatric feeding solutions.